Literature DB >> 28160262

Comparison between the summed difference score and myocardial blood flow measured by 13N-ammonia.

Raffaele Giubbini1, Alessia Peli2, Elisa Milan3, Roberto Sciagrà4, Luca Camoni2, Domenico Albano2, Mattia Bertoli2, Mattia Bonacina2, Federica Motta2, Massimo Statuto2, Carlo Alberto Rodella5, Antonio De Agostini5, Raffaella Calabretta4, Francesco Bertagna2.   

Abstract

BACKGROUND: Both the myocardial perfusion pattern and myocardial blood flow (MBF) are used to assess patients with suspected coronary artery disease (CAD). The aim of this study was to compare the perfusion pattern (using the summed difference score [SDS]) to MBF in a consecutive group of patients undergoing PET/CT with 13 N-ammonia (13NH3).
METHODS: 47 consecutive patients, aged 65 ± 12 years (42 men) with known or suspected CAD, underwent vasodilator stress/rest PET/CT with 13NH3 for clinical indications. The SDS was determined by a commercially available software based on a 17-segment model. MBF was measured at rest and during hyperemia by dynamic acquisition and single-compartment model analysis. From the rest and stress MBF, the absolute difference (stress-rest) in myocardial blood flow defined as difference in myocardial blood flow (DMBF) was derived.
RESULTS: There were no significant differences between patients with no ischemia (SDS ≤ 1) and those with ischemia (SDS > 1) in CFR (2.84 ± 0.73 vs 2.63 ± 0.89, P = NS) and DMBF (1.34 ± 0.45 vs 1.24 ± 0.53 mL·minute-1·g-1, P = NS). There were however significant regional differences (141 different vascular territories in 47 patients) between these two groups (CFR: 2.84 ± 0.95 vs 2.16 ± 0.57, P < .001 and DMBF: 1.39 ± 0.6 vs 0.87 ± 0.39, P < .0001). The correlation between regional CFR and regional DMBF with SDS was significant (y = 2.7145e-0.059x R = 0.358 and y = 1.2769e-0.119x R = 0.44)
CONCLUSION: The SDS is the difference between two measurements (stress-rest) and it correlates better with regional DMBF, which is another measurement that reflects the difference between stress and rest. The correlation is better on regional than global basis.

Entities:  

Keywords:  Coronary blood flow; Coronary flow reserve; Myocardial perfusion imaging: PET; N-13 ammonia

Mesh:

Substances:

Year:  2017        PMID: 28160262     DOI: 10.1007/s12350-017-0789-z

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  13 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  J Nucl Cardiol       Date:  2002 Mar-Apr       Impact factor: 5.952

Review 2.  Prognostic value of gated myocardial perfusion SPECT.

Authors:  Leslee J Shaw; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

3.  Absolute figures are better than percentages.

Authors:  Paolo G Camici
Journal:  JACC Cardiovasc Imaging       Date:  2009-06

4.  American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET.

Authors:  Timothy M Bateman; Vasken Dilsizian; Rob S Beanlands; E Gordon DePuey; Gary V Heller; David A Wolinsky
Journal:  J Nucl Med       Date:  2016-08-25       Impact factor: 10.057

5.  Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography.

Authors:  Rory Hachamovitch; Sean W Hayes; John D Friedman; Ishac Cohen; Daniel S Berman
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

6.  Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve.

Authors:  Bernhard A Herzog; Lars Husmann; Ines Valenta; Oliver Gaemperli; Patrick T Siegrist; Fabian M Tay; Nina Burkhard; Christophe A Wyss; Philipp A Kaufmann
Journal:  J Am Coll Cardiol       Date:  2009-07-07       Impact factor: 24.094

7.  Absolute Myocardial Blood Flow and Flow Reserve Assessed by Gated SPECT with Cadmium-Zinc-Telluride Detectors Using 99mTc-Tetrofosmin: Head-to-Head Comparison with 13N-Ammonia PET.

Authors:  Rene Nkoulou; Tobias A Fuchs; Aju P Pazhenkottil; Silke M Kuest; Jelena R Ghadri; Julia Stehli; Michael Fiechter; Bernhard A Herzog; Oliver Gaemperli; Ronny R Buechel; Philipp A Kaufmann
Journal:  J Nucl Med       Date:  2016-06-30       Impact factor: 10.057

8.  The strange case of the [13N]NH3: validation of the production process for human use.

Authors:  Massimo Statuto; Elisa Galli; Francesco Bertagna; Elena Migliorati; Isabella Zanella; Diego Di Lorenzo; Antonio De Agostini; Carlo Rodella; Pietro Apostoli; Luigi Caimi; Raffaele Giubbini; Giorgio Biasiotto
Journal:  Nucl Med Commun       Date:  2016-04       Impact factor: 1.690

9.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

10.  Positron emission tomography myocardial perfusion and glucose metabolism imaging.

Authors:  Josef Machac; Stephen L Bacharach; Timothy M Bateman; Jeroen J Bax; Robert Beanlands; Frank Bengel; Steven R Bergmann; Richard C Brunken; James Case; Dominique Delbeke; Marcelo F DiCarli; Ernest V Garcia; Richard A Goldstein; Robert J Gropler; Mark Travin; Randolph Patterson; Heinrich R Schelbert
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 3.872

View more
  5 in total

1.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2018. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2019-01-02       Impact factor: 5.952

2.  Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy.

Authors:  Hulya Yalcin; Ines Valenta; Min Zhao; Abdel Tahari; Dai-Yin Lu; Takahiro Higuchi; Fatih Yalcin; Nagehan Kucukler; Yalda Soleimanifard; Yun Zhou; Martin G Pomper; Theodore P Abraham; Ben Tsui; Martin A Lodge; Thomas H Schindler; M Roselle Abraham
Journal:  J Nucl Cardiol       Date:  2018-01-22       Impact factor: 5.952

Review 3.  13N-NH3 PET/CT in oncological disease.

Authors:  Domenico Albano; Raffaele Giubbini; Francesco Bertagna
Journal:  Jpn J Radiol       Date:  2019-10-10       Impact factor: 2.374

4.  Comparison of left ventricle mechanical dyssynchrony parameters in ischemic and non-ischemic patients using 13N-NH3 PET/CT.

Authors:  Angelica Mazzoletti; Domenico Albano; Francesco Bertagna; Claudio Tinoco Mesquita; Raffaele Giubbini
Journal:  J Nucl Cardiol       Date:  2021-01-04       Impact factor: 3.872

5.  Radiopharmaceutical tracers for cardiac imaging.

Authors:  Osamu Manabe; Tatsuya Kikuchi; Arthur J H A Scholte; Mohammed El Mahdiui; Ryuichi Nishii; Ming-Rong Zhang; Eriko Suzuki; Keiichiro Yoshinaga
Journal:  J Nucl Cardiol       Date:  2017-12-01       Impact factor: 5.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.